Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Aplenc

Showing results (101-110 of 254) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531Jessica A Pollard, Michael Loken, Robert B Gerbing, et al.
Life Science Alliance|August 27, 2024
Identification of single-cell blasts in pediatric acute myeloid leukemia using an autoencoderAlice Driessen, Susanne Unger, An-Phi Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2020
Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology GroupTodd M Cooper, Michael J Absalon, Todd A Alonzo, et al.
Haematologica|March 26, 2026
HLA-DR expression at diagnosis is not predictive of relapse risk post allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupVasant Chinnabhandar, Michael R Verneris, Kirk R Schultz, et al.
Journal of Patient Safety|September 27, 2021
Challenges and Barriers to Adverse Event Reporting in Clinical Trials: A Children's Oncology Group ReportTamara P Miller, Melissa Z Marx, Christopher Henchen, et al.
British Journal of Haematology|February 2, 2017
Using electronic medical record data to report laboratory adverse eventsTamara P Miller, Yimei Li, Kelly D Getz, et al.
Cancer|September 13, 2016
Low rates of pregnancy screening in adolescents before teratogenic exposures in a national sample of children's hospitalsPooja Rao, Yimei Li, Kelly D Getz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 27, 2007
Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injuryJacqui M Marzec, Jason D Christie, Sekhar P Reddy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapyNancy J Bunin, Stella M Davies, Richard Aplenc, et al.
JACC. Cardiooncology|December 2, 2020
Cardiology Involvement in Patients with Breast Cancer Treated with TrastuzumabBiniyam G Demissei, Srinath Adusumalli, Rebecca A Hubbard, et al.
Pageof 26

Showing results (101-110 of 254) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531Jessica A Pollard, Michael Loken, Robert B Gerbing, et al.
Life Science Alliance|August 27, 2024
Identification of single-cell blasts in pediatric acute myeloid leukemia using an autoencoderAlice Driessen, Susanne Unger, An-Phi Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2020
Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology GroupTodd M Cooper, Michael J Absalon, Todd A Alonzo, et al.
Haematologica|March 26, 2026
HLA-DR expression at diagnosis is not predictive of relapse risk post allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupVasant Chinnabhandar, Michael R Verneris, Kirk R Schultz, et al.
Journal of Patient Safety|September 27, 2021
Challenges and Barriers to Adverse Event Reporting in Clinical Trials: A Children's Oncology Group ReportTamara P Miller, Melissa Z Marx, Christopher Henchen, et al.
British Journal of Haematology|February 2, 2017
Using electronic medical record data to report laboratory adverse eventsTamara P Miller, Yimei Li, Kelly D Getz, et al.
Cancer|September 13, 2016
Low rates of pregnancy screening in adolescents before teratogenic exposures in a national sample of children's hospitalsPooja Rao, Yimei Li, Kelly D Getz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 27, 2007
Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injuryJacqui M Marzec, Jason D Christie, Sekhar P Reddy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapyNancy J Bunin, Stella M Davies, Richard Aplenc, et al.
JACC. Cardiooncology|December 2, 2020
Cardiology Involvement in Patients with Breast Cancer Treated with TrastuzumabBiniyam G Demissei, Srinath Adusumalli, Rebecca A Hubbard, et al.
Pageof 26